142 related articles for article (PubMed ID: 10968482)
1. Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid.
Erbayat Altay E; Serdaroğlu A; Tümer L; Gücüyener K; Hasanoğlu A
J Pediatr Endocrinol Metab; 2000; 13(7):933-9. PubMed ID: 10968482
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bone mineral density in children receiving antiepileptic drugs.
Akin R; Okutan V; Sarici U; Altunbas A; Gökçay E
Pediatr Neurol; 1998 Aug; 19(2):129-31. PubMed ID: 9744632
[TBL] [Abstract][Full Text] [Related]
3. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine.
Rieger-Wettengl G; Tutlewski B; Stabrey A; Rauch F; Herkenrath P; Schauseil-Zipf U; Schoenau E
Pediatrics; 2001 Dec; 108(6):E107. PubMed ID: 11731634
[TBL] [Abstract][Full Text] [Related]
5. Effect of carbamazepine and valproate on bone mineral density.
Ecevit C; Aydoğan A; Kavakli T; Altinöz S
Pediatr Neurol; 2004 Oct; 31(4):279-82. PubMed ID: 15464641
[TBL] [Abstract][Full Text] [Related]
6. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
Tsukahara H; Kimura K; Todoroki Y; Ohshima Y; Hiraoka M; Shigematsu Y; Tsukahara Y; Miura M; Mayumi M
Pediatr Int; 2002 Jun; 44(3):247-53. PubMed ID: 11982890
[TBL] [Abstract][Full Text] [Related]
8. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Serin HM; Koç ZP; Temelli B; Esen İ
Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
[TBL] [Abstract][Full Text] [Related]
9. Effect of carbamazepine and valproate on bone mineral density.
Sheth RD; Wesolowski CA; Jacob JC; Penney S; Hobbs GR; Riggs JE; Bodensteiner JB
J Pediatr; 1995 Aug; 127(2):256-62. PubMed ID: 7636651
[TBL] [Abstract][Full Text] [Related]
10. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years.
Kafali G; Erselcan T; Tanzer F
Clin Pediatr (Phila); 1999 Feb; 38(2):93-8. PubMed ID: 10047942
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of antiepileptic drugs on bone mineral density.
Babayigit A; Dirik E; Bober E; Cakmakci H
Pediatr Neurol; 2006 Sep; 35(3):177-81. PubMed ID: 16939856
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral metabolism changes in epileptic children receiving valproic acid.
Oner N; Kaya M; Karasalihoğlu S; Karaca H; Celtik C; Tütüncüler F
J Paediatr Child Health; 2004 Aug; 40(8):470-3. PubMed ID: 15265190
[TBL] [Abstract][Full Text] [Related]
13. Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3.
Kumandas S; Koklu E; Gümüs H; Koklu S; Kurtoglu S; Karakukcu M; Keskin M
J Pediatr Endocrinol Metab; 2006 Apr; 19(4):529-34. PubMed ID: 16759039
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of bone mineral density using digital image processing in children receiving anticonvulsants].
Suzuki K; Ueda S; Umezu R; Matsuoka H; Sugihara S
No To Hattatsu; 2007 Sep; 39(5):351-5. PubMed ID: 17879608
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
Chou IJ; Lin KL; Wang HS; Wang CJ
Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
[TBL] [Abstract][Full Text] [Related]
16. BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.
Lambrinoudaki I; Kaparos G; Armeni E; Alexandrou A; Damaskos C; Logothetis E; Creatsa M; Antoniou A; Kouskouni E; Triantafyllou N
Eur J Neurol; 2011 Jan; 18(1):93-8. PubMed ID: 20500803
[TBL] [Abstract][Full Text] [Related]
17. Effects of valproic acid on bone mineral density and bone metabolism: A meta-analysis.
Fan D; Miao J; Fan X; Wang Q; Sun M
Seizure; 2019 Dec; 73():56-63. PubMed ID: 31756600
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children.
Demircioğlu S; Soylu A; Dirik E
Pediatr Neurol; 2000 Aug; 23(2):142-6. PubMed ID: 11020639
[TBL] [Abstract][Full Text] [Related]
19. Effects of carbamazepine, eslicarbazepine, valproic acid and levetiracetam on bone microarchitecture in rats.
Diemar SS; Sejling AS; Eiken P; Ellegaard M; Ding M; Andersen NB; Jørgensen NR
Pharmacol Rep; 2020 Oct; 72(5):1323-1333. PubMed ID: 32193854
[TBL] [Abstract][Full Text] [Related]
20. [Effect of topiramate and carbamazepine on bone metabolism in children with epilepsy].
Zhang J; Wang KX; Wei Y; Xu MH; Su JM; Bao YG; Zhao SY
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Feb; 12(2):96-8. PubMed ID: 20199720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
